NFE2L2 and prostate carcinoma: Similarly, low Nrf2 expression was associated with biochemical recurrence in prostate cancer (PRAD-GSE21034) (P = 0.00279)[43] (Figure 7B), but we found no relation positive or negative to prognosis in any of the other cancers studied (detailed in Additional file11: Table S2).